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Abstract
Smoothened (Smo) is a member of the Frizzled (FzD) class of G-protein-coupled-receptors 
(GPCRs), and functions as the key transducer in the Hedgehog (Hh) signalling pathway. Smo has 
an extracellular cysteine-rich domain (CRD), indispensable for its function and downstream Hh 
signalling. Despite its essential role, the functional contribution of the CRD to Smo signalling has 
not been clearly elucidated. However, given that the FzD CRD binds to the endogenous Wnt 
ligand, it has been proposed that the Smo CRD may bind its own endogenous ligand. Here we 
present the NMR solution structure of the Drosophila Smo CRD, and describe interactions 
between the glucocorticoid budesonide (Bud) and the Smo CRDs from both Drosophila and 
human. Our results highlight a function of the Smo CRD, demonstrating its role in binding to 
small molecule modulators.
Smoothened (Smo), a member of the Frizzled (FzD) class of G-protein coupled receptors 
(GPCRs) is an integral member of the Hedgehog (Hh) signal transduction cascade, first 
identified through genetic analysis in fruit fly Drosophila melanogaster1–4. The Hh pathway 
plays an important role during embryogenesis controlling cell maturation, differentiation and 
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proliferation5,6. Disruption of Hh signalling during development leads to a plethora of 
developmental anomalies7,8. Conversely, ectopic Hh signalling during adult life contributes 
to tumour development and progression, particularly in cancers including medulloblastoma, 
basal cell carcinoma and rhabdomyosarcoma9. Consequently, the pathway is an important 
therapeutic target in oncology and regenerative medicine.
The Hh signal is transduced in a sequential manner that is initiated by the endogenous 
ligand–Indian, Sonic or Desert Hh binding to the twelve trans-membrane protein Patched 
(Ptc) to attenuate its housekeeping inhibition of Smo10–13. Smo then translocates to the cell 
membrane in Drosophila, or the primary cilium in vertebrates, and induces downstream 
signalling to the Gli/Cubitus interruptus (Ci) transcription factors5,13. The crystal structure 
of the seven trans-membrane (7TM) domain of human Smo was recently elucidated14. This 
structure revealed the canonical GPCR 7TM helical fold along with the conformation of the 
extra-cellular loop (ECL) and an extracellular linker domain (ECLD), both of which are 
stabilized by disulphide bonds between the conserved cysteine residues14,15. However, the 
major portion of the Smo extracellular domain (ECD) is the cysteine-rich domain (CRD) 
which was not included in the crystal structure of the Smo receptor14.
The CRDs of FzD family GPCRs possess modest homology. Nevertheless, the cysteines in 
this domain are highly conserved16,17. While the CRD of FzD plays an essential role in Wnt 
ligand binding and receptor dimerization16,18 the role of the Smo CRD is not clear although 
it has been shown that the Smo CRD is indispensable for Hh signalling in both Drosophila 
and vertebrates19,20. Drosophila and vertebrate Smo lacking the CRD fail to cycle to the 
plasma membrane or primary cilium to induce maximum signalling19,20. Furthermore, in 
Drosophila CRD deletion mutants fail to dimerize, suggesting that the CRD may govern 
Smo dimerization21. Based upon its functional importance, and the observation that the 
related FzD CRD binds to Wnt, it has been speculated that the Smo CRD may facilitate 
binding of an as yet unidentified, endogenous small molecule that modulates Smo signalling 
activity in the presence of Hh19. Recent studies have identified two major groups of small 
molecules capable of modulating Smo signalling activity: hydroxyl-sterols and 
glucocorticoids, both of which modulate Hh signalling through governing sub-cellular 
localization and activity of Smo22,23. Twenty hydroxycholesterol (20-OHC) and budesonide 
(Bud) have been reported to bind to a Smo domain distinct from the orthosteric site present 
in the trans-membrane core, previously demonstrated to bind the inhibitory small molecule 
cyclopamine22–24. Recent reports also indicate that 20-OHC binds the vertebrate Smo 
CRD25,26. Therefore, we hypothesized that the CRD of Smo may act as an allosteric binding 
site for Bud and additional small molecule Smo modulators.
To test this hypothesis, and to gain more insight into the functional significance of the Smo 
CRD, we performed structure-function studies. Here, we present the first solution structure 
of the Drosophila Smo CRD. We demonstrate that the CRD possesses a conserved pocket 
that contributes to the binding and allosteric regulation by the small molecule Bud.
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Results
The Smo CRD is essential for Hh signalling
The Smo CRD is essential for regulating its subcellular localization and signalling19–21. The 
cysteines in this domain are conserved from Drosophila through vertebrates (Fig.1). Despite 
this essential role, the functional contribution of the CRD to Smo regulation has remained 
unclear. To gain functional insight into the role of the CRD, we generated a mutant lacking 
this domain (ΔCRD; V85-K202), and tested its ability to rescue Hh-dependent reporter gene 
induction following knockdown of endogenous smo in cultured Clone 8 (Cl8) cells27. 
Consistent with previous in vivo studies, we found that deletion of this domain ablates Smo 
signalling capacity in vitro (Fig 2). In order to better dissect this essential functional domain, 
we studied the structure of the Smo CRD using NMR (Nuclear Magnetic Resonance) 
methods.
Solution structure of the Smo CRD
A recombinant Drosophila Smo CRD (V85-K202) was expressed and purified using the E. 
coli expression system. For the purpose of NMR studies, 15N and 13C labelled protein was 
prepared in 10 mM deuterated acetic acid buffer and 10% D2O (volume/volume) at pH 5. 
Resonance assignments were performed using the standard triple resonance strategy 
for 13C, 15N labelled proteins28. In the 2D 1H-15N HSQC spectra, all the amide resonances 
of the 118 residues of the CRD could be observed except D116. D116 is in the loop region 
preceding the first helix and hence could be undergoing motions in the intermediate time 
scale resulting in peak broadening for the backbone amide; nevertheless, all the side chain 
resonances of this residue were observed. Using the structural information obtained from the 
NMR studies, one hundred structures were calculated and the 20 structures with the lowest 
energy are represented as an ensemble (Fig. 3a). The statistical details for the NMR structure 
calculation are given in Table 1. The structure has no distance violation > 0.03 Å and no 
angle violations > 1°. The structure with the lowest energy is used to describe the secondary 
structure elements (Fig. 3b). The tertiary fold of the Smo CRD is very similar to that of the 
FzD CRD16,18 (Fig.3c, cyan compared to red).
The cysteines in the Smo CRD
Structure analysis shows that the eight conserved cysteines in Smo CRD form four 
disulphide bonds. The chemical shifts observed for the cysteine C-alpha and C-beta carbons 
are suggestive that all the cysteines are oxidized29. The disulphide bond pattern was 
determined based on the intermolecular NOEs observed between the β-protons of the 
cysteine residues and is as follows: C90-C155, C100-C148, C139-C179 and C172-C194 
(Fig. 3a). In order to study the structural and biological relevance of these disulphide bonds, 
we mutated the cysteines individually to alanine, and checked the ability of the cysteine to 
alanine Myc-Smo mutants to rescue Hh induced reporter gene in a smo knockdown 
background. C100A, C148A, C172A and C194A were able to rescue Hh-induced reporter 
gene induction to wild-type levels (Fig. 2) indicating that the C100-C148 and C172-C194 
disulphide bonds are not essential for a functional CRD. Conversely, C90A, C139A, C155A 
and C179A showed attenuated rescue of the Hh-induced reporter gene induction (Fig. 2) 
suggesting that the C90-C155 and C139-C179 disulphide play critical roles in maintaining 
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the integrity of the CRD structure. Indeed, additional indirect immunofluorescence revealed 
that Smo cysteine to alanine mutants that were compromised in their ability to signal were 
retained in the endoplasmic reticulum (ER), overlapping with the ER marker protein 
Calreticulin-GFP-KDEL (Fig. 4a and Supplementary Fig. S1a). ER retention is likely due to 
altered protein folding resulting from loss of essential disulphide bridges. However, such 
misfolding did not trigger obvious degradation of Smo protein, as the cysteine to alanine 
mutants were present at protein levels similar to and greater than that of wild type Smo 
(Supplementary Fig. S1b lane 2 compared to 3–6). Though it is difficult to understand the 
cause of higher protein levels for cysteine to alanine mutants, we speculate that it may be 
due to the misfolded Smo mutants failing to exit the ER and cycle to the plasma membrane 
to be phosphorylated and desensitized like the wild type protein30,31.
The cysteines in the ECLD of Smo
In addition to the cysteines of the CRD (V85-K202), the Drosophila Smo ECD has five 
other conserved cysteines, at positions 84, 203, 218, 238 and 242. In the 3D structure of the 
Drosophila Smo CRD the N- and the C-termini are in close proximity (Fig. 3b); implying 
that C84 and C203 may form a disulphide bond. Nevertheless, mutation of C84 and C203 to 
alanine does not alter the ability of Smo to rescue reporter gene induction in the smo 
knockdown background (Fig.2), suggesting that they are either not engaged in a disulphide 
bond or the disulphide bond is not crucial in defining the 3D fold of the CRD. However, 
when C218, C238 and C242 of the ECLD were mutated individually to alanine, they 
expressed at near-normal levels (Supplementary Fig. S1c), but failed to rescue Hh-induced 
reporter gene induction following endogenous smo knockdown (Fig.2). C218, C238 and 
C242 of Drosophila Smo are homologous to C193, C213 and C217 of human Smo (Fig. 4b). 
The crystal structure of the human Smo shows that the ECLD is stabilized towards the ECL 
by disulphide bonds between C193 and C213 of the ECLD and C217 of the ECLD and 
C295 ECL1 loop14 (Fig. 4b). Hence, C218 and C238 in the ECLD of Drosophila Smo may 
form a disulphide bond and C242 in the ECLD is likely to form a disulphide bond with 
C320 in ECL1 of Drosophila Smo. Thus, cysteines both in the Smo CRD and ECD linker 
play an important role in maintaining the conformation of Smo essential for downstream 
signalling.
Drosophila Smo CRD binds to the glucocorticoid Bud
Smo activity can be modulated by small molecule inhibitors such as cyclopamine, which 
binds in the orthosteric binding site located within a cavity in the 7TM bundle14,24. The FzD 
CRD binds to its endogenous ligand Wnt underscoring the ligand binding capability of the 
CRDs16,18. Therefore we decided to test whether the Drosophila CRD might bind to 20-
OHC or Bud. Due to a solubility issue with 20-OHC, we carried out all experiments with 
Bud. We used NMR chemical-shift perturbations (CSPs) to identify the residues that are 
involved in binding32 since this method allows us to determine precisely the amino acid 
residues involved in the interaction33. Despite recent reports stating the inability of 20-OHC 
to bind to the Drosophila Smo protein we tested if Bud bound to Drosophila Smo CRD25. In 
the 2D 1H-15N HSQC spectra of Smo CRD in the absence and presence of an increasing 
concentration of the ligand Bud, CSPs induced by the binding of Bud are clearly observed 
indicating Bud bound to the CRD (Supplementary Figs. S2a and S3). The normalized CSP 
Rana et al. Page 4
Nat Commun. Author manuscript; available in PMC 2014 June 19.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
for each residue of Smo in the presence of Bud is shown in Fig. 5a. The residues that have 
significant CSP are further shown in the back-bone “ribbon” representation of the Smo 
CRD, wherein the thickness of the ribbon is proportional to CSP values observed on binding 
of Bud to Smo CRD (Fig. 5b). The results show that the residues of Smo CRD that have the 
largest CSPs induced by the bound Bud are located between the first helix and the C-
terminus 310 helical domain as it folds back between the first and second helix. As a control 
we tested the ability of cyclopamine to bind and induce CSPs within the Smo CRD and Smo 
CRD did not bind to cyclopamine at a ratio of 1:2 of protein to ligand24 (Supplementary Fig. 
S2b).
Based on the NMR studies, we generated the docked structure of Bud bound to Smo CRD 
using the program HADDOCK34. The CSP data on the Smo CRD and the bound Bud were 
used as ambiguous restraints (Supplementary Table S1) for docking and generating one 
thousand binding poses. The structure with the lowest binding energy was selected and this 
agrees with the CSP data on the Smo CRD (Fig. 5b). The modelled structure showed that 
Bud is buried into a hydrophobic surface formed by the residues A132, H135, F187, F188 
and F191 on the Smo CRD (Fig. 5c and 5d). F191 is conserved in the vertebrate Smo family 
whereas F188 is a tryptophan in vertebrate Smo (Fig.1). The conservation of these residues 
in the vertebrate family, and the recent demonstration that the domain engages 20-OHC25,26, 
suggests that this pocket may have an important role in binding an as yet unidentified 
allosteric regulator of Drosophila Smo. To determine whether Bud would attenuate 
signalling by the Drosophila Smo protein, we treated Cl8 cells with increasing 
concentrations of Bud, and observed a ~20–40% reduction in Hh-induced reporter gene 
activity (Supplementary Fig. S4). Thereby we speculate that Bud acts as a weak, synthetic 
mimic of an endogenous ligand for the Drosophila Smo CRD, displacing it from this 
binding pocket.
The human Smo CRD binds to the glucocorticoid Bud
Recent reports indicate that 20-OHC binds the vertebrate Smo CRD25,26. We therefore 
tested the binding of Bud to human Smo CRD. The recombinant human Smo CRD (G65-
G177) was expressed and purified using the E. coli expression system. Similar to the studies 
of Drosophila Smo CRD, 15N and 13C labelled protein was prepared in 10 mM deuterated 
acetic acid buffer and 10% D2O (volume/volume) at pH 5. In the 2D 1H-15N HSQC spectra 
of human Smo CRD, all the amide resonances of the 113 residues were assigned except two 
residues, L73 and R74. NMR titration experiments were performed to determine the specific 
residues involved in ligand binding. The 2D 1H-15N HSQC spectra of human Smo CRD in 
the absence and presence of an increasing concentration of Bud showed that Bud bound to 
human Smo CRD as well (Supplementary Figs. S5 and S6). The normalized CSP for each 
residue of human Smo CRD in the presence of Bud is shown in Fig. 6a. Comparing with 
Drosophila Smo CRD (Fig. 5a), Bud binds to human CRD in a similar fashion. However, 
there are some clear differences. For example, a smaller number of residues in human Smo 
CRD had CSPs induced by the binding of Bud, and the absolute values of CSPs observed in 
human Smo CRD are smaller. Moreover, the binding affinities measured from different 
residues in human Smo CRD are clustered around 45 μM whereas those obtained from 
residues in Drosophila Smo CRD range from 200–1000 μM indicating that Bud binding 
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induced backbone conformational stabilization in Drosophila CRD35. Nevertheless, judged 
by the NMR titration data, it seemed that Bud binds to human Smo CRD with higher affinity 
(Supplementary Figs. S3 and S6). Although NMR is a useful method for determining 
specific protein ligand interactions in solution, it is not the ideal method for calculating 
dissociation constants36. The associated systemic error in calculating Kd values from NMR 
is likely caused by the averaging effect during NMR experiments37. Kd values calculated by 
this method can only be treated as the upper limit for interaction. Therefore we validated the 
binding affinity measurements using additional experiments. Indeed, using Bio-Layer 
Interferometry (BLI) we found that Bud bound to Drosophila Smo CRD with a Kd value of 
120 ± 98 μM and bound to human Smo CRD with a Kd value of 52 ± 16 μM (Fig. 6b and c). 
Both NMR and BLI data suggest that Bud binds to human Smo CRD better than Drosophila 
Smo CRD.
Discussion
Classical GPCR signalling involves binding of ligands to the extracellular regions of the 
receptor which induces a conformational change in the core of the 7TM domains to 
modulate signalling events in the cytoplasm38,39. Several studies have reported that GPCRs 
are regulated by natural ligands, as well as exogenous small molecules38–41. Furthermore, 
GPCRs have been reported to possess allosteric binding sites distinct from their orthosteric 
sites, that when bound by small molecule modulators, induce distinct signal outputs42,43. In 
the FzD GPCR the CRD functions to bind to the endogenous ligand Wnt, which interacts 
with the CRD at two sites16,18. The palmitate modification on Wnt engages a groove on the 
FzD8 CRD termed site 1, whereas the second Wnt binding site on FzD8 CRD (site 2) is 
located on the opposite end and involves protein-protein interactions18. In the current 
studies, we showed that Bud interacts with Smo CRD residues analogous to site 1. Within 
the site 1 of human Smo R161 demonstrated the highest observed CSP. L108, W109, G111, 
L112, G162 and W163 also demonstrated CSPs. Consistent with these findings, a recent 
report shows that mutating the homologous murine Smo CRD residues “WGL” (W113, 
G115, and L116) and R165 to alanine blocked the specific binding of 20-OHC to the Smo 
CRD and attenuated its signalling ability26. Furthermore, mutating murine L112 (human 
L108) and W113 (human W109) to equivalent Drosophila Smo CRD residues blocked 20-
OHC binding25, suggesting that the site 1 is involved in the binding of hydroxyl-sterols and 
glucocorticoids. Drosophila Smo protein does not bind to 20-OHC in vitro25, however that 
does not preclude the fact that there could be an as yet unidentified endogenous ligand for 
Drosophila Smo CRD binding to this pocket. Consistent with this hypothesis, genetic 
experiments suggest that phospho-lipids could serve as the physiological molecules 
regulating Drosophila Smo activity44.
The cache of identified Smo modulators dock on distinct sites on Smo to regulate 
signalling14,24,45,46. The extracellular region of Smo may be flexible (Fig.7a). Small 
molecules may bind in the cavity of the 7TM domains (Fig. 7b right) and modulate 
signalling irrespective of CRD binding14,24. In the present study, we provide structural 
evidence identifying the specific residues in the Smo CRD that interact with the small 
molecule modulator Bud. We speculate that these same residues bind the endogenous 
allosteric activator, and that activator binding to the CRD may cause a conformational shift 
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that bridges the extracellular domains and the 7TM domains (Fig. 7b middle), similar to 
what is observed for class B GPCRs40,41,47. These shifts may enhance communication 
between the CRD and the 7TM domains to trigger structural alterations in the core and the 
cytoplasmic domains to regulate downstream signalling (Fig. 7).
Currently, the only FDA approved therapeutic aimed at targeting Smo is the antagonist 
Vismodegib, which is likely to bind in the cavity of the 7TM domains and also make 
contacts with the ECLD and ECL14,24,48,49. Despite initial clinical success, resistance to this 
compound has been observed48. Thus, the need exists for developing second-generation 
drugs that can overcome the acquired drug resistance. Based upon our data, we speculate 
that the Bud binding cleft in the Smo CRD could be evaluated for the development of novel 
antagonists of Smo. Bud is a clinically approved anti-inflammatory glucocorticoid steroid 
and has the advantage of acting on wild type as well as Vismodegib resistant Smo23,50. Thus 
future investigation and identification of Bud-like molecules which bind to the Smo CRD 
with high affinity may represent a novel class of Smo regulators.
Methods
Vector construction
The Drosophila Smo CRD (V85-K202) was amplified from pET-SmoN3. The forward and 
the reverse primers used were 5'- ATA TAT CAT ATG GTC CGA CGT GCC CGT TGC- 3' 
and 5'- ATA TAC TCG AGT TAT TTC GTC GGA AAG AGT G-3'. The PCR amplified 
product was cloned in pET-28a (+) and validated by nucleotide sequencing. To generate 
cysteine to alanine mutants, Smo mutant expression vectors pAc-myc-smo51 was mutated 
using QuickChange II Site Directed Mutagenesis Kit (Stratagene) using primers generated 
per manufacturer's instructions. All mutations were verified by sequencing. Smo 5'UTR 
dsRNA was generated using the Megascript T7 kit (Life Technologies)15. The human Smo 
CRD (G65–G177) was amplified from the smo cDNA purchased from Origene. The forward 
and the reverse primers used were 5'-TAT ATC ATA TGG GCC GGG CTG CCC CCT GC 
-3' and 5'- ATA TAT CTC GAG TTA GCC TTC AGG GAA GCG -3' respectively. The 
PCR amplified product was cloned in pET-28a (+) and validated by nucleotide sequencing.
Protein expression and purification
For the expression of both the Drosophila and human recombinant protein pET28a-smoCRD 
was transformed in to BL21 (DE3) cells. The cells were grown in MOPS (3-(N-morpholino) 
propane sulfonic acid) minimal media supplemented with 15N ammonium chloride and 13C 
glucose as the sole source of nitrogen and carbon respectively. Cells were grown to an 
optical density (OD600) of 0.6 and induced with 1mM IPTG (isopropyl β-D-1-
thiogalactopyrasonide). The protein of interest accumulated in the inclusion bodies and was 
refolded from the same by the method of rapid dilution. The protein was further purified by 
reverse phase HPLC using a C18 column (Hitachi) and gel filtration (AKTA) on a Hiload 
16/60 Superdex 200 preparative grade column (GE Healthcare).
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NMR Spectroscopy
A 200 μM pure monomeric sample of the recombinant Drosophila (V85–K202) or human 
(G65–G177) Smo CRD was prepared in 10 mM deuterated acetic acid buffer and 10% D20 
(v/v) for NMR experiments. All spectra were recorded using either 1H, 15N labelled 
or 1H, 15N, and 13C labelled protein on Bruker Avance 600 MHz or 800 MHz NMR 
spectrometers equipped with 1H/15N /13C detect, TCI triple resonance cryogenic probes at 
25°C. All spectra were processed using Topspin (Bruker Biospin) 3.0 NMR software and 
analysed using the program, CARA (computer aided resonance assignment)52. The 
backbone chemical shift assignment were obtained using the standard triple- resonance 
assignment strategy using the two dimensional 1H-15N HSQC and three dimensional 
HNCA, HNCACB, CBCA(CO)NH, HN(CA)CO and HNCO NMR experiments. The 
aliphatic side chain resonance assignments were obtained using HBHA(CBCACO)NH and 
(H)CCH-TOCSY. Distance constraints for the structure calculation were derived 
from 15N; 13C resolved 1H-1H NOESY with a mixing time of 100 ms. Chemical shift 
perturbation experiments were carried out using 15N labelled Drosophila or human Smo 
CRD. 1H-15N HSQC spectra were recorded in the absence and presence of an increasing 
concentration of Bud. Kd values were calculated by a nonlinear least-squares analysis in the 
program Origin using the equation [1]
[1]
where [L] is the concentration of the ligand, [P] is the concentration of the protein, Δδ is the 
observed chemical shift change and Δδmax is the normalized chemical shift change at 
saturation, calculated using equation [2]
[2]
where Δδ is the chemical shift in p.p.m.
A stock solution of 50 mM Bud (Sigma) was made in deuterated DMSO for use in NMR 
titration experiments. The concentration of DMSO in the NMR titration experiment was 
maintained at or below 1%. A control experiment was done by titrating 1% DMSO and no 
CSPs were observed.
Structure calculation and refinement
An automated program UNIO53 was used for the NOE assignment and all these assignments 
were manually checked. Integrated NOE peaks were calibrated and converted to distance 
constraints with the program CALIBA54. A total of 1421 meaningful distance constraints 
were derived from the NMR data and used as input for structure calculation using the 
program CYANA 2.154. The structure was refined using 139 dihedral angle constraints and 
22 hydrogen bond constraints. The dihedral angles were generated by the program TALOS
+55 which uses six kinds (HN, HA, CA, CB, CO, N) of chemical shift values for a given 
residue as input to give the phi, psi angles. The Ramachandran statistics are as follows: most 
favourable 72.5 %, additionally allowed 25.7 %, generously allowed 1.6%, and disallowed 
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0.2 %. Also, four disulphide bonds were added as additional constraints between residues, 
C90–C155, C100–C148, C139–C179 and C172–C194. A total of 100 conformers were 
initially generated and 20 conformers with the lowest target function were used to represent 
the 3-D NMR structure.
Structural modelling of Smo CRD in complex with Bud
To calculate the structure of the CRD-Bud complex, we used the simulated annealing 
protocol in the program CNS34. All calculations were done using the program HADDOCK 
2.1(High Ambiguity Driven protein-protein Docking)34. Topology and parameter files for 
Bud were generated by using xplo2d, and the charge parameters of Bud were calculated by 
using the antechamber module in the AMBER10 software package56. We used ambiguous 
distance restraints resulting from the CSPs of 1H-15N Smo CRD (Supplementary Table S1). 
To define the active and passive residues we also calculated a relative accessible surface 
area by NACCESS57. One thousand initial structures of the Smo CRD-Bud complex were 
generated and the final ten structures of the complex with the lowest energy were selected 
manually that were consistent with the CSPs on Smo CRD following Bud binding.
Lysate Preparation and Functional Assays
Expression vectors and dsRNA were transfected using Lipofectamine 2000 according to the 
manufacturer's instructions. For rescue reporter experiments ~1.5 × 106 Cl8 cells were co-
transfected with 500 ng Smo 5 'UTR dsRNA, 100 ng ptcΔ136-luciferase27 10 ng pAc-
Renilla51, and unless otherwise indicated, 100 ng of pAc-Hh (+Hh) and 50 ng of the 
indicated pAc-myc-smo expression vector. DNA and RNA content were normalized with 
control dsRNA and/or pAc5.1A. Forty-eight hours post-transfection, cells were lysed and 
luciferase activity measured using the Dual Luciferase Assay System (Promega)15. For all 
reporter assays, experiments were performed a minimum of two times in duplicate or 
triplicate and all data pooled. Error bars indicate standard error of the mean (s.e.m.).
For the Bud treatment, Cl8 cells were treated with the indicated concentration of Bud 
(Sigma) or DMSO vehicle. Bud was added in serum-free M3 media (Sigma) 24 hours post 
transfection. Cells were treated with Bud for 24 hours prior to measuring luciferase activity. 
Experiments were performed at least three times in duplicate and all data pooled.
For biochemical analysis, ~6 × 106 Cl8 cells were transfected with 5 μg of the indicated 
pAc-myc-smo expression vector and 3 μg of pAc-Hh, as indicated. DNA content was 
normalized with empty pAc5.1A. Forty-eight hours post transfection, cells were lysed in 
NP-40 lysis buffer (1% NP-40, 150 mM NaCl, 50 mM Tris, 50 mM NaF, 0.5 mM DTT and 
1X PIC (Roche), pH 8.0), and centrifuged for 10 minutes at 2000xg. The resulting 
supernatants were analysed by SDS-PAGE and western blot using anti-Myc (Roche, Cat # 
11667149001 diluted 1:5000) and anti-Kinesin (Cytoskeleton, AKIN01-A, diluted 
1:10,000). Full scans of the western blots are represented in Supplementary Figure S7. 
Antibodies were diluted in Tris-buffered saline with 0.1% Tween and 5% powdered milk.
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Immunofluorescence and microscopy
For immunofluorescence experiments, ~6 × 106 Cl8 cells were transfected with 2 μg of 
Calreticulin-GFP-KDEL58, 2 μg pAc Hh, and 2 μg of the indicated pAc-myc-smo expression 
vector. DNA content was normalized with pAc5.1A. Forty-eight hours post-transfection, 
cells were re-plated on chamber slides, fixed using 4% formaldehyde and immunostained 
using anti-Myc (Roche, Cat # 11667149001)15, Calreticulin-GFP-KDEL was used to mark 
the endoplasmic reticulum, and DAPI was used to mark the nucleus. Confocal images were 
collected using a Zeiss LSM 510 NLO Meta Microscope.
Bio-Layer Interferometry Assay
The Octet RED instrument (FortéBio) was used to measure the interaction of Drosophila 
Smo CRD (or human Smo CRD) and Bud. Super streptavidin (SSA) sensors were used to 
catch the biotinylated target protein. Biotinylation of the target protein was achieved by 
incubating 200 μl of 1.0 mg/ml EZ-Link NHS-LC-Biotin (Thermo Sci.) with 100 μl of 0.2 
mM target protein in 0.1 M potassium phosphate buffer, pH 6.5 for 15 hours on a rocking 
platform at room temperature. Excess unreacted biotin was removed by three successive 
dialysis under the same buffer conditions. Prior to the start of the assay the SSA sensors 
were pre-wet in 0.1M potassium phosphate buffer, pH 6.5 with 0.01 % Trion-X100 for 10 
minutes. For the binding affinity assay 3 ~ 5 μM biotinylated protein was immobilized on 
the SSA sensor by incubating for 30 minutes. Subsequently the free streptavidin sites were 
quenched by incubating with 0.5 mM biocytin (Thermo Sci.) for 10 minutes. Excess protein 
and biocytin were removed by washing with 0.1M potassium phosphate, pH 6.5 for 10 
minutes. To determine the binding affinity of Drosophila Smo CRD (or human Smo CRD) 
to Bud, three different concentrations of Bud (62, 41, and 31 μM) were used. The 
association step for 50s was followed by the dissociation step for 100s. The assay buffer 
used was 0.1 M potassium phosphate, pH 6.5 with 0.5% DMSO. Biocytin-loaded SSA 
sensor without loading biotinylated protein was used as a control to correct the systematic 
optical artefacts and baseline drifts. All steps were performed at 30 °C with 1000 rpm rotary 
shaking. The processed data were fitted locally with the integrated fitting function using the 
1:1 binding model in FortéBio analysis software (v6.4). The kinetic constants kon (on-rate 
constant), koff (off-rate constant) and Kd were calculated from curve fitting.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Sequence alignment of the Smo CRD
Primary sequence alignment of the Drosophila (D), human (H), mouse (M) and chicken (C) 
Smo CRD with that of mouse FzD8 CRD and mouse secreted Frizzled Related Protein 3 
(sFRP3). The residues conserved in Smo and FzD CRD are shown in red, whereas the 
residues conserved only in the Smo CRD are shown in blue. The cysteine in FzD not 
conserved in Smo is underlined and in green. The disulphide bond pattern for the Smo CRD 
is shown in thick purple lines. The secondary structure elements are shown above and below 
the primary sequence. The residues highlighted in orange indicate the “site 1” residues of 
mouse FzD8 that interact with the palmitate modification on the ligand Wnt. The residues 
highlighted in green indicate the “site 2” on mouse FzD8 that interact with the amino acid 
sidechains on the opposite side of Wnt. The sequence alignment was generated using 
ClustalW2.
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Figure 2. Identification of cysteines essential for Smo signalling
CRD residues C90, C139, C155, C179 and the Smo ECLD residues C218, C238 and C242 
are required for proper Hh reporter gene induction. Mutation of C84, 100,148,172,194,203 
to alanine did not compromise the ability of Smo protein to induce the Hh reporter gene 
activity, and behaved similarly to the wild type protein. Percent activity for each of the 
experimental assays is shown relative to control. The control level of Hh-induced, ptcΔ136-
luciferase activity for control dsRNA was set to 100%. For all conditions, luciferase activity 
is normalized to pAc-renilla control. Experiments were performed a minimum of two times 
in duplicate or triplicate and all data pooled. Error bars indicate standard error of the mean 
(s.e.m.).
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Figure 3. Solution structure of the Smo CRD
(a) Stereo view of the backbone atoms (N, Cα, C') of the 20 superimposed structures of Smo 
CRD with the lowest energy. The disulphides are indicated in yellow and are labelled for 
clarity. (b) Ribbon diagram of the Smo CRD showing the secondary structure elements. The 
structure with the lowest energy is used to describe the secondary structure elements. The 
colour scheme is as follows: Cyan: Alpha helices; Red: β strands; Yellow: 310 helices Grey: 
random coil. (c) Superimposition of the Smo CRD with FzD CRD. The Smo CRD is 
represented in cyan and the FzD8 CRD is represented in red. The helices in both proteins are 
shown as cylinders and the beta-strands as arrowheads. All figures were generated using 
PyMol.
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Figure 4. Sub cellular localization of the cysteines essential for Smo signalling
(a) CRD mutants with compromised signalling activity have altered sub cellular 
localization. Cl8 cells expressing wild type or the indicated Myc-Smo mutant protein, in the 
presence of Hh (+) or empty vector control, were examined by indirect 
immunofluorescence. Wild type Smo translocates to the plasma membrane in response to 
Hh, whereas Smo CRD cysteine to alanine mutant C90A that was required for maximal Hh 
reporter gene induction was largely retained in the ER. Smo was detected using anti-Myc 
(red), Calreticulin-GFP-KDEL marks the ER (green) and DAPI (blue) marks the nucleus. 
Scale bar: 10uM (b) Sequence alignment of the Drosophila (D) Smo ECLD and ECL1 with 
the human (H) Smo ECLD and ECL1. The cysteines engaged in disulphide bond formation 
in human Smo are conserved in Drosophila. The red lines indicate the disulphide bond 
pattern.
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Figure 5. Drosophila Smo CRD binds to the glucocorticoid Bud
(a) CSPs of Smo CRD upon addition of Bud are plotted versus residue numbers. The red 
line indicates CSP greater than 0.01 ppm. The residues labelled in black form the Bud-
binding pocket on Smo CRD as analysed from the HADDOCK docking experiments. The 
mouse FzD8-Wnt interacting “site 1” and “site 2” residues are shown in orange and green 
respectively. The corresponding secondary structure elements of the Drosophila Smo CRD 
are represented below the plot. (b) “Ribbon” representation of the Smo CRD. The backbone 
thickness of the ribbon is directly proportional to the weighted sum (in ppm) of the 1H 
and 15N chemical shifts upon binding to the ligand Bud. (c and d) Results of the 
HADDOCK docking of Bud on Smo CRD. (c) The aromatic side chains of the Bud 
contacting Smo CRD residues are shown. (d) Surface representation of the residues that 
interact with Bud are shown in yellow and the positively charged H135 is shown in blue.
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Figure 6. Analysis of the binding of Bud to human Smo CRD
(a) CSPs of human Smo CRD upon addition of Bud are plotted versus residue numbers. 
Dotted red line indicates CSP greater than 0.01 ppm. L108, W109, G111, L112 and R161 
are homologous to the mouse Smo residues that interact with 20-OHC. G162 is homologous 
to Drosophila F187 and W163 is homologous to Drosophila Smo F188 that interacts with 
Bud. All these residues map to the “site 1” of mouse FzD8-Wnt interaction. “Site 1” and 
“site 2” residues of mouse FzD8-Wnt interaction are shown in orange and green 
respectively. The secondary structure elements as in Drosophila Smo CRD structure are 
shown below the plot. (b) BLI binding assays show that Bud binds to Drosophila Smo CRD. 
The super streptavidin sensors with biotinylated Drosophila Smo CRD were exposed to 
three different concentrations of Bud (62, 41, and 31 μM). The processed data were fitted 
locally with the integrated fitting function by a 1:1 binding model (orange line). The 
respective Kd values obtained by curve fitting were 89 μM (62 μM Bud, black line), 74 μM 
(41 μM Bud, green line), 59 μM (41 μM Bud, red line), 318 μM (41 μM Bud, magenta line), 
93 μM (31 μM Bud, cyan line), and 85 μM (31 μM Bud, blue line). The average Kd value of 
Drosophila Smo CRD for Bud was 120 ± 98 μM. (c) BLI binding assays show that Bud 
binds to human Smo CRD. The experimental and data analysis procedure were same as 
described above. The respective Kd values obtained by curve fitting were 74 μM (62 μM 
Bud, black line), 37 μM (41 μM Bud, green line), 44 μM (41 μM Bud, red line) and 54 μM 
(31 μM Bud, blue line). The average Kd value of human Smo CRD for Bud was 52 ± 16 μM.
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Figure 7. A novel model for Smo allosteric regulation
(a) Smo CRD may be flexible. The disulphide bonds stabilizing Smo extracellular linker and 
extracellular loop are shown in red lines. (b) Smo has more than one binding site. We 
propose that molecules like Bud bind to the Smo CRD (left, red rectangle) to alter its 
conformation and attenuate its signalling activity. Cyclopamine and vismodegib are known 
to bind near the orthosteric binding site located in the cavity of the Smo 7TM domains 
(right, pink inverted triangle). We speculate that there is the possibility of a class of 
molecules (middle, yellow star) which would bind to the CRD and cause a conformational 
change of the Smo extracellular structures to bring it closer to the 7TM domains. This in 
turn might change the conformation of the trans-membrane domains to regulate signalling.
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Table 1
NMR and refinement statistics used for calculating the structure of Smo CRD
Protein
NMR distance & dihedral constraints
Distance constraints
Total NOE 1421
Intra-residue 430
Inter-residue
Sequential (|i−j| = 1) 422
Medium-range (|i−j < 4) 248
Long-range (|i−j > 5) 321
Hydrogen bonds 22
Total dihedral angle restraints 139
phi 71
psi 68
Structure Statistics
Violations (mean and s.d.)
Distance constraints (Å) 0.0176±0.0019
Dihedral angle constraints (°) 0.7607±0.0849
Max. dihedral angle violation (°) 0.9547±0.0849
Max. distance constraint violation (Å) 0.0238±0.0152
Average pairwise r.m.s.d.** (Å)
V85-K202
Heavy 1.28±0.19
Backbone 0.7±0.15
Average pairwise r.m.s.d.** (Å)
V85-E177
Heavy 1.08±0.19
Backbone 0.4±0.15
**Average r.m.s deviation from the lowest energy structure was calculated among 20 structures with the lowest energy.
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